# Medicare Program; Exclusion of Vendor Purchases Made Under the Competitive Acquisition Program (CAP) for Outpatient Drugs and Biologicals Under Part B for the Purpose of Calculating the Average Sales Price (ASP)
> **Centers for Medicare and Medicaid Services** · Interim final rule with comment period. · Published 2005-11-21 · Effective 2005-11-21 · 70 FR 70478
## Document
- **Document number:** 05-22175
- **Category:** medicare
- **Sub-agency:** Centers for Medicare and Medicaid Services
- **Federal Register citation:** 70 FR 70478
- **CFR reference:** 42 CFR 414
- **Publication date:** 2005-11-21
- **Effective date:** 2005-11-21
- **HHS docket:** CMS-1325-IFC3
## Abstract

This interim final rule with comment period provides clarification and solicits comments on the relationship between drugs supplied under the Competitive Acquisition Program (CAP) for Part B Drugs and Biologicals and the calculation of Average Sales Price (ASP). (For purposes of this interim final rule, the term "drug" refers to drugs and biologicals.) This interim final rule with comment period also will exclude units of drugs supplied under the CAP from ASP calculations for a period of up to 3 years, at which time the policy will be re-evaluated. In addition, this rule revises the definition of unit to reflect the exclusion of units of CAP drugs administered to beneficiaries by participating CAP physicians.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2005/11/21/05-22175/medicare-program-exclusion-of-vendor-purchases-made-under-the-competitive-acquisition-program-cap)
---
*AI Analytics · CC0 1.0*